CMV Clinical Trials

7 recruiting

Frequently Asked Questions

Common questions about CMV clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 30 trials

Recruiting

The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise

HPVHSVEBV+2 more
National Institute of Allergy and Infectious Diseases (NIAID)600 enrolled1 locationNCT01011712
Recruiting
Phase 3

Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients

Kidney Transplant; ComplicationsKidney DiseasesCytomegalovirus (CMV)
University of California, San Francisco360 enrolled5 locationsNCT06798909
Recruiting
Phase 2

CMV CTLs in Neonates With CMV Infection

Congenital Cytomegaloviral (CMV) Disease
New York Medical College23 enrolled4 locationsNCT05564598
Recruiting
Phase 2

Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection

CMV ViremiaBrain Cancer Metastatic
The Methodist Hospital Research Institute28 enrolled1 locationNCT07383649
Recruiting

Immunological and Virological Prognostic Markers of Human Cytomegalovirus (HCMV) Congenital Infection in Pregnant Women With Primary HCMV Infection.

Human Cytomegalovirus (HCMV)
Fondazione IRCCS Policlinico San Matteo di Pavia90 enrolled1 locationNCT07477925
Recruiting
Phase 3

A Study of Maribavir in Chinese Adults With Cytomegalovirus (CMV) Infections

Cytomegalovirus (CMV)
Takeda20 enrolled12 locationsNCT06439342
Recruiting
Phase 4

Combination Letermovir and Standard of Care Antiviral for Enhanced Antiviral Response in Cytomegalovirus Infection in Lung Transplant Recipients

CMVLung Transplant Recipient
University Health Network, Toronto40 enrolled1 locationNCT07235683
Recruiting
Not Applicable

Efficacy of Extended Letermovir Prophylaxis to Prevent CMV Reactivation in High-Risk Chinese Adults Undergoing Allogeneic HSCT

Cytomegalovirus InfectionsCMV
The First Affiliated Hospital of Soochow University330 enrolled1 locationNCT06812598
Recruiting

A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation

Kidney DiseaseCytomegalovirus (CMV)Kidney Failure
Takeda10 enrolled25 locationsNCT06243731
Recruiting
Phase 2

Phase II Trial of Maribavir for CMV in Patients With Lymphoid Malignancy on Bispecific Antibodies

Cytomegalovirus (CMV)
Seoul National University Hospital20 enrolled1 locationNCT07014319
Recruiting

A Study of LIVTENCITY (Maribavir) in Adults With Cytomegalovirus (CMV) Infection After Transplantation in South Korea

Cytomegalovirus (CMV)
Takeda168 enrolled1 locationNCT06555432
Recruiting
Phase 1Phase 2

CMVIG Prophylaxis in Belatacept Conversion Kidney Transplant Recipients

Kidney Transplant; ComplicationsCMV
University of Minnesota30 enrolled1 locationNCT07096453
Recruiting
Phase 2

Study Evaluating the Efficacy and Safety of Artesunate

CMV Infection
Amivas Inc.90 enrolled2 locationsNCT06853184
Recruiting

A Survey of Maribavir Tablets in Participants With Cytomegalovirus Infection

Cytomegalovirus (CMV)
Takeda250 enrolled1 locationNCT06577363
Recruiting
Phase 2Phase 3

Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant

Heart Transplant InfectionCMV ViremiaHeart Transplant Failure and Rejection
Columbia University150 enrolled2 locationsNCT07079735
Recruiting

A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection in Belgium

Cytomegalovirus (CMV)
Takeda75 enrolled9 locationsNCT06677892
Recruiting
Phase 3

Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections

Stem Cell Transplant ComplicationsEBV InfectionCMV Infection+1 more
Tobias Feuchtinger149 enrolled33 locationsNCT04832607
Recruiting
Phase 3

A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)

Cytomegalovirus (CMV)
Takeda80 enrolled47 locationsNCT05319353
Recruiting

A Study of Maribavir in Adults and Children With Post-transplant Cytomegalovirus (CMV) Infection in Argentina

Cytomegalovirus (CMV)
Takeda10 enrolled1 locationNCT06213974
Recruiting
Phase 2

CMV-TCIP Directed Letermovir Prophylaxis After Allo-SCT

CMV
University of California, Irvine50 enrolled1 locationNCT06453460